SUMMARY CSF immunocytochemistry with monoclonal antibodies was compared with conventional cytology to determine its sensitivity in detecting malignant cells in patients with meningeal carcinomatosis. One hundred and eighteen samples were investigated. Cytology was tumour positive in 83 samples and immunocytochemistry in 85. Dissimilar results between the two diagnostic methods were noted in 12 specimens, invariably occurring in samples with a low cell count and obtained from treated patients. Combined use of the two methods led to a 9% increase of sensitivity in detecting malignant cells compared with cytology alone. It is concluded that immunocytochemistry is of minor help in the problem of false-negative cytology in meningeal carcinomatosis.
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Infiltration of the leptomeninges by metastases from solid tumours is a relatively rare condition. It For cytological and immunocytochemical examination equal aliquots of 2 ml. CSF from each puncture were sampled and immediately transported to the laboratories for further processing. For both examinations slides were prepared by the cytocentrifuge technique (Shandon Elliot cytospin).
For immunocytochemical examination, in principle at can be expected, the false-negative rate seems to be lower in studies concerning patients with meningeal carcinomatosis without extensive post-mortem investigation.5 15 Except for a positive cytology, the bead-like defects occasionally found at myelography or contrast enhancement in the cisterns and cerebral sulci on CT scans are also considered as conclusive evidence of the diagnosis meningeal carcinomatosis. An increase of biochemical tumour markers in the CSF, as well as other CSF abnormalities like high pressure, hypoglycorrachia and an increased protein concentration, are more frequently encountered than a positive cytology.6 However, these findings are less specific than CSF cytology and insufficient for establishing the diagnosis unless typical clinical signs of meningeal carcinomatosis are present.
Immunocytochemical staining of CSF tumour cells can be of great value in identifying an unknown primary tumour.9 Apart from this increased specificity immunocytochemistry has been reported to be more sensitive than routine cytology in detecting malignant cells: the detection of malignant cells in six patients with meningeal carcinomatosis increased from 25% to 100% by applying immunocytochemistry.'0 In our experience, however, malignant cells can, in cases of meningeal carcinomatosis, usually clearly be distinguished from non-malignant cells by conventional cytology. In the present study the results of cytology and immunocytochemistry were almost similar in positive as well as in negative findings, including many specimens with a very low cell count. The sensitivity in the detection of malignant cells increased by less than 2% by applying immunocytochemistry, while it increased by 9% when both diagnostic methods were used in combination. We examined particularly samples from patients with treated meningeal 
